Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$8.23B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 3 |
NVIDIA
NVDA
|
+$1.45B |
| 4 |
T-Mobile US
TMUS
|
+$1.41B |
| 5 |
Broadcom
AVGO
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.04B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.7B |
| 3 |
Amazon
AMZN
|
+$2.11B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Merck
MRK
|
+$1.79B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.15% |
| 2 | Healthcare | 19.44% |
| 3 | Financials | 13.51% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Lexicon Pharmaceuticals
LXRX
$1.03B
| $1.24M | ﹤0.01% |
738,628
+52,210
| +8% | +$93.7K |
|
1527
Orrstown Financial Services
ORRF
$854M
| $1.24M | ﹤0.01% |
45,187
+24
| +0.1% | +$623 |
|
|
BRKL
1528
DELISTED
Brookline Bancorp
BRKL
| $1.24M | ﹤0.01% |
+147,998
| New | +$1.3M |
|
|
ATXS
1529
DELISTED
Astria Therapeutics
ATXS
| $1.24M | ﹤0.01% |
135,736
+19,679
| +17% | +$192K |
|
1530
Conagra Brands
CAG
$7.09B
| $1.22M | ﹤0.01% |
43,076
-3,341
| -7% | -$100K |
|
1531
Shore Bancshares
SHBI
$815M
| $1.22M | ﹤0.01% |
106,905
| – | – |
|
1532
Viemed Healthcare
VMD
$360M
| $1.22M | ﹤0.01% |
+185,944
| New | +$1.4M |
|
1533
Ligand Pharmaceuticals
LGND
$6.11B
| $1.21M | ﹤0.01% |
14,402
+1,854
| +15% | +$148K |
|
1534
First Community Corp
FCCO
$326M
| $1.2M | ﹤0.01% |
69,838
| – | – |
|
1535
Biohaven
BHVN
$2.11B
| $1.2M | ﹤0.01% |
34,695
+6,418
| +23% | +$254K |
|
1536
Cabaletta Bio
CABA
$448M
| $1.19M | ﹤0.01% |
158,809
-849,450
| -84% | -$10.4M |
|
|
THRD
1537
DELISTED
Third Harmonic Bio
THRD
| $1.18M | ﹤0.01% |
90,913
+6,703
| +8% | +$82.9K |
|
1538
International Flavors & Fragrances
IFF
$21.7B
| $1.17M | ﹤0.01% |
12,309
-697
| -5% | -$63.9K |
|
1539
Kroger
KR
$34.8B
| $1.17M | ﹤0.01% |
23,390
-5,897
| -20% | -$318K |
|
1540
Innoviva
INVA
$1.6B
| $1.16M | ﹤0.01% |
70,905
+5,296
| +8% | +$82.2K |
|
1541
TG Therapeutics
TGTX
$7.71B
| $1.16M | ﹤0.01% |
65,071
-3,088,522
| -98% | -$49.3M |
|
1542
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $1.16M | ﹤0.01% |
15,000
| – | – |
|
1543
Steris
STE
$21.6B
| $1.16M | ﹤0.01% |
5,270
+461
| +10% | +$100K |
|
1544
iShares MSCI Thailand ETF
THD
$369M
| $1.15M | ﹤0.01% |
+21,262
| New | +$1.23M |
|
1545
Toast
TOST
$20.1B
| $1.15M | ﹤0.01% |
+44,673
| New | +$1.08M |
|
1546
PUT
iShares MSCI EAFE ETF
EFA
$79.6B
| $1.15M | ﹤0.01% |
13,947
+6,972
| +100% | +$552K |
|
1547
Solventum
SOLV
$14.7B
| $1.15M | ﹤0.01% |
+21,668
| New | +$1.32M |
|
1548
Fulcrum Therapeutics
FULC
$286M
| $1.13M | ﹤0.01% |
182,729
+10,069
| +6% | +$76.3K |
|
1549
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $1.13M | ﹤0.01% |
6,197
| – | – |
|
|
PSTX
1550
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.13M | ﹤0.01% |
387,331
+30,435
| +9% | +$83.2K |
|
Similar funds
Wellington Management Group's Q2 2024 Portfolio in Review
As of Q2 2024, Wellington Management Group held 2,006 positions worth $560B, down 0.75% from $564B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wellington Management Group's Q2 2024 filing shows 120 new, 834 increased, 756 reduced and 132 closed positions. Its largest new stake was Pool Corp: 1,100,398 shares worth $338M. The largest sale was Meta Platforms (Facebook), an estimated $3.04B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Wellington Management Group's largest Q2 2024 buy was Pool Corp: 1,100,398 shares worth $338M.
- Wellington Management Group added most to Apple in Q2 2024, an estimated $8.23B increase.
- Wellington Management Group's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $3.04B.
- Wellington Management Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $850M.
- Wellington Management Group's ten largest holdings make up 24% of its $560B portfolio in Q2 2024.
- Wellington Management Group opened 120 new positions and closed 132 in Q2 2024.
- Wellington Management Group's portfolio value fell 0.75% quarter-over-quarter to $560B.
Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.